MedTrace Logo

Efficacy of a Dietary Supplement in Infants

NCT07341477 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2026-04-24

No results posted yet for this study

Summary

This is a double-blind, randomized, placebo-controlled nutritional study of healthy term infants. The primary objective of the trial is to demonstrate a favorable change in fecal microbiome composition in infants receiving a dietary supplement compared to infants receiving a placebo supplement.

Conditions

  • Healthy Infants

Interventions

DIETARY_SUPPLEMENT

Experimental Group

Dietary supplement in powder form

OTHER

Control Group (CG)

Placebo dietary supplement in powder form

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Dr. Mitzi Trinidad-Aseron · University of Perpetual Help Dalta Medical Center, Philippines

  • Dr. Maria Josefa Nantes · Silang Specialists Medical Center, Philippines

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Weeks
Max Age
21 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-06-30
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07341477 on ClinicalTrials.gov